Immunotherapy for Hepatocellular Carcinoma: Current Limits and Prospects

Immunotherapy for Hepatocellular Carcinoma: Current Limits and Prospects

Although many approaches have been used to treat hepatocellular carcinoma (HCC), the clinical benefits remain limited, particularly for late stage HCC. In recent years, studies have focused on immunotherapy for HCC. Immunotherapies have shown promising clinical outcomes in several types of cancers a...

Full description

Bibliographic Details
Main Authors: Cheng Zhong, Yirun Li, Jing Yang, Shengxi Jin, Guoqiao Chen, Duguang Li, Xiaoxiao Fan, Hui Lin
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-03-01
Series:Frontiers in Oncology
Subjects:
immunotherapy
hepatocellular carcinoma
immune tolerance
tumor mutational burden
tumor microenvironment
epigenetic modification
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.589680/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.589680/full

Similar Items